Exploring prophylactic co-trimoxazole regimens at the removal of temporary catheters to prevent urinary tract infections: a randomised placebo controlled pilot study
Phase 4
Withdrawn
- Conditions
- cystitisurinarary tract infection10004018
- Registration Number
- NL-OMON35979
- Lead Sponsor
- Spaarne Ziekenhuis
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Withdrawn
- Sex
- Not specified
- Target Recruitment
- 42
Inclusion Criteria
Temporary urinary catheter for minimal 2 days
Bacteriuria defined as more then 10^ 5 cfu/ ml
Age of 18 years or older
Signed informed consent
Exclusion Criteria
Antibiotic treatment of less than 1 week prior to the removal of the urinary catheter
Urogenital surgery
Pregnancy or breast feeding
Known allergy to sulfamethoxazol or trimetoprim
Renal insufficiency defined as MDRD less then 30ml/ minute
Symptomatic urinary tract infection
Co-medication interacting with sulfamethoxazole or trimetoprim upon discretion of the investigators
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>the course of the percentage of subjects with bacteriuria in seven days after<br /><br>intervention.</p><br>
- Secondary Outcome Measures
Name Time Method <p>the percentage of subjects with an urinary tract infection at any moment in<br /><br>seven days after intervention</p><br>